| Targeting ErbB3: the new RTK (id) on the prostate cancer block M K Jathal, L Chen, M Mudryj, P M Ghosh Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Formerly …, 2011 | 94 | 2011 |
| Dual EGFR/HER2 inhibition sensitizes prostate cancer cells to androgen withdrawal by suppressing ErbB3 L Chen, BA Mooso, MK Jathal, A Madhav, SD Johnson, E van Spyk, ... Clinical Cancer Research 17 (19), 6218-6228, 2011 | 74 | 2011 |
| Transcription of Nrdp1 by the androgen receptor is regulated by nuclear filamin A in prostate cancer RM Savoy, L Chen, S Siddiqui, FU Melgoza, B Durbin-Johnson, C Drake, ... Endocrine-related cancer 22 (3), 369-386, 2015 | 23 | 2015 |
| Dacomitinib, but not lapatinib, suppressed progression in castration-resistant prostate cancer models by preventing HER2 increase MK Jathal, TM Steele, S Siddiqui, BA Mooso, LS D’Abronzo, CM Drake, ... British journal of cancer 121 (3), 237-248, 2019 | 22 | 2019 |
| Prostate cancer and bone: clinical presentation and molecular mechanisms KV Wells, ML Krackeler, MK Jathal, M Parikh, PM Ghosh, JK Leach, ... Endocrine-related cancer 30 (9), 2023 | 7 | 2023 |
| Androgen receptor transcriptional activity is required for heregulin-1β–mediated nuclear localization of the HER3/ErbB3 receptor tyrosine kinase MK Jathal, S Siddiqui, DM Vasilatis, BPD Johnson, C Drake, BA Mooso, ... Journal of Biological Chemistry 299 (8), 2023 | 4 | 2023 |
| Overcoming EGFR-induced resistance to enzalutamide in castration-resistant prostate cancer TM Steele, MK Jathal, S Siddiqui, PM Ghosh Cancer Research 76 (14_Supplement), 4676-4676, 2016 | 3 | 2016 |
| Androgen receptor-dependent regulation of metabolism in high grade bladder cancer cells KD Katleba, MM Tsamouri, M Jathal, HB Baek, RB Armenta, CG Tepper, ... Scientific reports 13 (1), 1762, 2023 | 2 | 2023 |
| in vivo analysis of EGFR family signalling as a bypass mechanism in prostate cancer MK Jathal, TM Steele, S Siddiqui, BA Mooso, LS D’Abronzo, CM Drake, ... Cancer Research 76 (14_Supplement), 1303-1303, 2016 | 1 | 2016 |
| Amiloride Sensitizes Prostate Cancer Cells to the Reversible Tyrosine Kinase Inhibitor Lapatinib by Modulating ERBB3 Subcellular Localization MK Jathal, MM Mudryj, M Dall’Era, PM Ghosh Research Square, 2024 | | 2024 |
| Role of Nuclear ErbB3 localization in regulating ligand-dependent ErbB2-ErbB3 heterodimer activation and downstream targets in prostate cancer MK Jathal, MM Mudryj, PM Ghosh Cancer Research 84 (6_Supplement), 6264-6264, 2024 | | 2024 |
| Prolonged inhibition of androgen receptor signaling induces expression of Nuclear ErbB3 which renders prostate cancer cells susceptible to targeted inhibitors MK Jathal, MM Mudryj, PM Ghosh Cancer Research 84 (6_Supplement), 4619-4619, 2024 | | 2024 |
| The Regulation of Nuclear ErbB3 by the Androgen Receptor in Prostate Cancer Cells M Jathal, S Siddiqui, B Johnson, P Ghosh The FASEB Journal 35, 2021 | | 2021 |
| Overcoming EGFR and ERK-mediated resistance to enzalutamide in castration-resistant prostate cancer TM Steele, MK Jathal, S Siddiqui, S Qin, CG Tepper, RWV White, M Kohli, ... Cancer Research 79 (13_Supplement), 4842-4842, 2019 | | 2019 |
| Subcellular Localization of ErbB3/HER3 and its Interactions with the Androgen Receptor In Prostate Cancer MK Jathal University of California, Davis, 2018 | | 2018 |
| Selective pressure of anti-androgens on castration resistant prostate cancer TM Steele, MK Jathal, PM Ghosh INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE 38, S63-S63, 2016 | | 2016 |
| Increased ErbB3 and EGFR activity mediate lapatinib resistance in prostate cancer MK Jathal, TM Steele, BA Mooso, LS D'Abronzo, S Siddiqui, C Drake, ... Cancer Research 74 (19_Supplement), 3335-3335, 2014 | | 2014 |
| Identification of conditions of lapatinib effectiveness in prostate cancer. MK Jathal, BA Mooso, LS D'Abronzo, S Siddiqui, L Chen, E van Spyck, ... Cancer Research 73 (8_Supplement), 1323-1323, 2013 | | 2013 |
| Androgen receptor transcriptionally targets the ErbB3 regulator Nrdp1 in the presence of nuclear Filamin A. RM Savoy, L Chen, S Siddiqui, FU Melgoza, B Durbin-Johnson, M Roy, ... Cancer Research 73 (8_Supplement), 3578-3578, 2013 | | 2013 |
| Abstract A12: Identification of Nrdp1 as a novel androgen receptor transcription target differentially regulated in androgen-dependent and independent prostate cancer RM Savoy, L Chen, D Troyer, P Ghosh, W Fry, K Carraway, S Siddiqui, ... Clinical Cancer Research 18 (10_Supplement), A12-A12, 2012 | | 2012 |
